Sign in to continue:

Wednesday, April 8th, 2026

Breakout trading strategies

Theriva Biologics Receives FDA Agreement to Advance VCN-01 to Phase 3 Trial for Metastatic Pancreatic Cancer 1

Theriva Biologics Receives Positive FDA Feedback to Advance ...

Traeger, Inc. Files Form 8-K with SEC on March 17, 2026 Detailing Corporate Information and Stock Listing

Traeger, Inc. Announces 1-for-50 Reverse Stock Split and Ame...